The U.S. Court of Appeals for the Federal Circuit upheld a judgment of the U.S. District Court for the Southern District of California stating that Arthrex infringed three patents that KFx Medical possessed.
The judgment also found that the patents were valid, and awarded KFx Medical $29 million in damages. The District Court judge later awarded additional damages and interest, bringing the total judgment to over $35 million.
In 2011, KFx filed a complaint against Arthrex alleging claims of induced and contributory infringement of United States Patent Number 7,585,311. Previously, KFx had licensed the '311' family of patents to Johnson and Johnson and Smith & Nephew.
KFx Medical develops products for tissue fixation in numerous orthopedic surgical procedures of the shoulder, knee, foot and ankle.
More articles on devices:
8 core thoughts on the cervical total disc replacement market
10 key thoughts on the minimally invasive spine market — 2015
K2M files follow-on offering registration statement — 7 things to know